Literature DB >> 12727539

New substituted 2-(pyrazol-1-yl)-dialkylacetanilides with potential local anesthetic and antiarrhythmic action. Part II.

Mircea Iovu1, Christina Zalaru, Florea Dumitrascu, Constantin Draghici, Mircea Moraru, Elena Cristea.   

Abstract

Nine substituted 2-(pyrazol-1-yl)-dialkylacetanilides were synthesized by N-alkylation of pyrazole and its derivatives with several 2-iodoacetanilides. The new compounds exhibited local anesthetic and antiarrhythmic actions. They have been characterized by elemental chemical analysis, UV-Vis, IR, 1H NMR, 13C NMR, SM spectra and pharmacology research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727539     DOI: 10.1016/S0014-827X(02)00014-9

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  4 in total

1.  Synthesis and anti-HIV-1 screening of novel N'-(1-(aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(1H)-yl)acetohydrazides.

Authors:  Sana Aslam; Matloob Ahmad; Muhammad Zia-Ur-Rehman; Catherine Montero; Mervi Detorio; Masood Parvez; Raymond F Schinazi
Journal:  Arch Pharm Res       Date:  2013-07-10       Impact factor: 4.946

2.  Synthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety.

Authors:  Othman A Hamed; Noha Mehdawi; Adham Abu Taha; Emad M Hamed; Mohammed A Al-Nuri; Ayman S Hussein
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

3.  Ethyl 5-amino-1-(4-chloro-2-nitro-phen-yl)-1H-pyrazole-4-carboxyl-ate.

Authors:  Muhammad Zia-Ur-Rehman; Mark R J Elsegood; Jamil Anwar Choudary; Muhammad Fasih Ullah; Hamid Latif Siddiqui
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-10

4.  Synthesis, characterization and antimicrobial activity of some novel benzimidazole derivatives.

Authors:  Immadisetty Sri Krishnanjaneyulu; Govindaraj Saravanan; Janga Vamsi; Pamidipamula Supriya; Jarugula Udaya Bhavana; Mittineni Venkata Sunil Kumar
Journal:  J Adv Pharm Technol Res       Date:  2014-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.